|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
73,500,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Nuvalent is a biopharmaceutical company. Co.'s product candidate, NVL-520, is a ROS proto-oncogene 1 (ROS1)-selective inhibitor designed with the aim to address the clinical challenges of emergent treatment resistance, central nervous system (CNS)-related adverse events, and brain metastases that may limit the use of available ROS1 tyrosine kinase inhibitors. Co.'s another product candidate, NVL-655, is a brain-penetrant anaplastic lymphoma kinase (ALK)-selective inhibitor, designed with the aim to address the clinical challenges of emergent treatment resistance, CNS-related adverse events, and brain metastases that may limit the use of first-, second-, and third-generation ALK inhibitors.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
902,383 |
1,227,454 |
1,509,599 |
6,359,357 |
| Total Sell Value |
$87,158,156 |
$116,259,567 |
$137,776,574 |
$563,736,240 |
| Total People Sold |
8 |
8 |
8 |
10 |
| Total Sell Transactions |
25 |
49 |
72 |
134 |
| End Date |
2025-11-09 |
2025-08-08 |
2025-02-07 |
2024-02-08 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Noci Darlene |
Chief Development Officer |
• – – |
2026-01-29 |
4 |
AS |
$100.95 |
$561,422 |
D/D |
(5,500) |
58,117 |
|
- |
|
| Noci Darlene |
Chief Development Officer |
• – – |
2026-01-29 |
4 |
OE |
$27.85 |
$153,175 |
D/D |
5,500 |
63,617 |
|
- |
|
| Miller Deborah Ann |
Chief Legal Officer |
• – – |
2026-01-22 |
4 |
AS |
$110.16 |
$1,575,288 |
D/D |
(14,300) |
59,634 |
|
- |
|
| Miller Deborah Ann |
Chief Legal Officer |
• – – |
2026-01-22 |
4 |
OE |
$27.85 |
$398,255 |
D/D |
14,300 |
73,934 |
|
- |
|
| Miller Deborah Ann |
Chief Legal Officer |
• – – |
2026-01-21 |
4 |
AS |
$109.84 |
$76,888 |
D/D |
(700) |
59,634 |
|
- |
|
| Miller Deborah Ann |
Chief Legal Officer |
• – – |
2026-01-21 |
4 |
OE |
$27.85 |
$19,495 |
D/D |
700 |
60,334 |
|
- |
|
| Porter James Richard |
President and CEO |
• • – |
2026-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
46,250 |
324,879 |
|
- |
|
| Balcom Alexandra |
Chief Financial Officer |
• – – |
2026-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
17,500 |
99,233 |
|
- |
|
| Miller Deborah Ann |
Chief Legal Officer |
• – – |
2026-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
17,500 |
59,634 |
|
- |
|
| Noci Darlene |
Chief Development Officer |
• – – |
2026-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
17,500 |
58,117 |
|
- |
|
| Turner Christopher Durant |
Chief Medical Officer |
• – – |
2026-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
17,500 |
72,630 |
|
- |
|
| Pelish Henry E. |
Chief Scientific Officer |
• – – |
2026-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
17,500 |
83,388 |
|
- |
|
| Porter James Richard |
President and CEO |
• • – |
2026-01-06 |
4 |
AS |
$96.75 |
$927,244 |
D/D |
(9,543) |
278,629 |
|
- |
|
| Balcom Alexandra |
Chief Financial Officer |
• – – |
2026-01-06 |
4 |
AS |
$96.75 |
$309,081 |
D/D |
(3,181) |
81,733 |
|
- |
|
| Miller Deborah Ann |
Chief Legal Officer |
• – – |
2026-01-06 |
4 |
AS |
$96.75 |
$251,560 |
D/D |
(2,589) |
42,134 |
|
- |
|
| Noci Darlene |
Chief Development Officer |
• – – |
2026-01-06 |
4 |
AS |
$96.75 |
$309,081 |
D/D |
(3,181) |
40,617 |
|
- |
|
| Turner Christopher Durant |
Chief Medical Officer |
• – – |
2026-01-06 |
4 |
AS |
$96.75 |
$309,081 |
D/D |
(3,181) |
55,130 |
|
- |
|
| Pelish Henry E. |
Chief Scientific Officer |
• – – |
2026-01-06 |
4 |
AS |
$96.75 |
$258,848 |
D/D |
(2,664) |
65,888 |
|
- |
|
| Porter James Richard |
President and CEO |
• • – |
2026-01-05 |
4 |
AS |
$96.06 |
$1,741,016 |
D/D |
(17,890) |
288,172 |
|
- |
|
| Balcom Alexandra |
Chief Financial Officer |
• – – |
2026-01-05 |
4 |
AS |
$96.06 |
$412,239 |
D/D |
(4,236) |
84,914 |
|
- |
|
| Miller Deborah Ann |
Chief Legal Officer |
• – – |
2026-01-05 |
4 |
AS |
$96.06 |
$424,598 |
D/D |
(4,363) |
44,723 |
|
- |
|
| Noci Darlene |
Chief Development Officer |
• – – |
2026-01-05 |
4 |
AS |
$96.06 |
$412,239 |
D/D |
(4,236) |
43,798 |
|
- |
|
| Turner Christopher Durant |
Chief Medical Officer |
• – – |
2026-01-05 |
4 |
AS |
$96.06 |
$412,239 |
D/D |
(4,236) |
58,311 |
|
- |
|
| Pelish Henry E. |
Chief Scientific Officer |
• – – |
2026-01-05 |
4 |
AS |
$96.06 |
$242,905 |
D/D |
(2,496) |
68,552 |
|
- |
|
| Miller Deborah Ann |
Chief Legal Officer |
• – – |
2026-01-02 |
4 |
AS |
$100.03 |
$1,005,114 |
D/D |
(10,000) |
49,086 |
|
- |
|
392 Records found
|
|
Page 1 of 16 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
